Anticancer Mechanisms and Potential Anticancer Applications of Antimicrobial Peptides and Their Nano Agents

References

• Hashim D, Boffetta P, Vecchia CL, et al. The global decrease in cancer mortality: trends and disparities. Ann Oncol. 2016;27(5):926. doi:10.1093/annonc/mdw027
   PubMed Web of Science ®Google Scholar
• Munker S, Gerken M, Fest P, et al. Chemotherapy for metastatic colon cancer: no effect on survival when the dose is reduced due to side effects. BMC Cancer. 2018;18(1):455. doi:10.1186/s12885-018-4380-z
   PubMedGoogle Scholar
• Nakashima-Kamimura N, Mori T, Ohsawa I, Asoh S, Ohta S. Molecular hydrogen alleviates nephrotoxicity induced by an anti-cancer drug cisplatin without compromising anti-tumor activity in mice. Cancer Chemother Pharmacol. 2009;64(4):753–761. doi:10.1007/s00280-008-0924-2
   PubMed Web of Science ®Google Scholar
• Norouzi‐Barough L, Sarookhani MR, Sharifi M, et al. Molecular mechanisms of drug resistance in ovarian cancer. J Cell Physiol. 2018;233(6):4546.
   PubMed Web of Science ®Google Scholar
• Chatterjee S, G Damle S, K Sharma A. Mechanisms of resistance against cancer therapeutic drugs. Curr Pharm Biotechnol. 2014;15(12):1105.
   PubMed Web of Science ®Google Scholar
• Stone TA, Cole GB, Ravamehr-Lake D, Nguyen HQ, Deber CM. Positive charge patterning and hydrophobicity of membrane-active antimicrobial peptides as determinants of activity, toxicity, and pharmacokinetic stability. J Med Chem. 2019;62(13):6276–6286. doi:10.1021/acs.jmedchem.9b00657
   PubMed Web of Science ®Google Scholar
• Gupta S, Bhatia G, Sharma A, Saxena S. Host defense peptides: an insight into the antimicrobial world. J Oral Maxillofac Pathol. 2018;22(2):239.
   PubMedGoogle Scholar
• Di YP. Antimicrobial peptides in host defense against drug-resistant bacterial and viral infections. Curr Med Chem. 2020;27(9):1385–1386. doi:10.2174/092986732709200327085156
   PubMed Web of Science ®Google Scholar
• Schröder-Borm H, Bakalova R, Andr J. The NK-lysin derived peptide NK-2 preferentially kills cancer cells with increased surface levels of negatively charged phosphatidylserine. FEBS Lett. 2005;579(27):6128–6134. doi:10.1016/j.febslet.2005.09.084
   PubMed Web of Science ®Google Scholar
• Oliva R, Del Vecchio P, Grimaldi A, et al. Membrane disintegration by the antimicrobial peptide (P)GKY20: lipid segregation, domain formation, budding and micellization. PCCP. 2019;21(7):3989–3998. doi:10.1039/C8CP06280C
   PubMed Web of Science ®Google Scholar
• Parchebafi A, Tamanaee F, Ehteram H, Ahmad E, Nikzad H, Haddad Kashani H. The dual interaction of antimicrobial peptides on bacteria and cancer cells; mechanism of action and therapeutic strategies of nanostructures. Microb Cell Fact. 2022;21(1):118. doi:10.1186/s12934-022-01848-8
   PubMed Web of Science ®Google Scholar
• Nguyen LT, Haney EF, Vogel HJ. The expanding scope of antimicrobial peptide structures and their modes of action. Trends Biotechnol. 2011;29(9):464–472. doi:10.1016/j.tibtech.2011.05.001
   PubMed Web of Science ®Google Scholar
• Maraming P, Klaynongsruang S, Boonsiri P, et al. The cationic cell-penetrating KT2 peptide promotes cell membrane defects and apoptosis with autophagy inhibition in human HCT 116 colon cancer cells. J Cell Physiol. 2019;234(12):22116–22129. doi:10.1002/jcp.28774
   PubMed Web of Science ®Google Scholar
• Luo X, Teng Q-X, Dong J-Y, et al. Antimicrobial peptide reverses ABCB1-mediated chemotherapeutic drug resistance. Front Pharmacol. 2020;11:1208. doi:10.3389/fphar.2020.01208
   PubMed Web of Science ®Google Scholar
• Kawami M, Yamada Y, Issarachot O, Junyaprasert VB, Yumoto R, Takano M. P-gp modulating effect of Azadirachta indica extract in multidrug-resistant cancer cell lines. Pharmazie. 2018;73(2):104–109. doi:10.1691/ph.2018.7116
   PubMed Web of Science ®Google Scholar
• Dennison SR, Wallace J, Harris F, Phoenix DA. Amphiphilic alpha-helical antimicrobial peptides and their structure/function relationships. Protein Pept Lett. 2005;12(1):31. doi:10.2174/0929866053406084
   PubMed Web of Science ®Google Scholar
• Banković J, Andrä J, Todorović N, et al. The elimination of P-glycoprotein over-expressing cancer cells by antimicrobial cationic peptide NK-2: the unique way of multi-drug resistance modulation. Exp Cell Res. 2013;319(7):1013.
   PubMed Web of Science ®Google Scholar
• Lu J, Chen ZW. Isolation, characterization and anti-cancer activity of SK84, a novel glycine-rich antimicrobial peptide from Drosophila virilis. Peptides. 2010;31(1):44–50. doi:10.1016/j.peptides.2009.09.028
   PubMed Web of Science ®Google Scholar
• Smolarczyk R, Cichoń T, Szala S, et al. Peptydy – nowa klasa leków przeciwnowotworowych[Peptides: a new class of anticancer drugs]. Postepy Hig Med Dosw. 2009;63(835515):360. Polish.
   Google Scholar
• Rothan HA, Ambikabothy J, Ramasamy TS, Rashid NN, Yusof R. A preliminary study in search of potential peptide candidates for a combinational therapy with cancer chemotherapy drug. Int J Pept Res Ther. 2019;25:115–122.
   Web of Science ®Google Scholar
• Gallo RL, Huttner KM. Antimicrobial peptides: an emerging concept in cutaneous biology. J Invest Dermatol. 1998;111(5):739–743. doi:10.1046/j.1523-1747.1998.00361.x
   PubMed Web of Science ®Google Scholar
• Zasloff M. Antimicrobial peptides of multicellular organisms. Nature. 2002;415(6870):389–395. doi:10.1038/415389a
   PubMed Web of Science ®Google Scholar
• Lidholm DA, Gudmundsson GH, Xanthopoulos KG, Boman HG. Insect immunity: cDNA clones coding for the precursor forms of cecropins A and D, antibacterial proteins from Hyalophora cecropia. FEBS Lett. 1987;226:8.
   Web of Science ®Google Scholar
• Gudmundsson GH, Lidholm DA, Asling B, Gan RB, Boman HG. The cecropin locus. Cloning and expression of a gene cluster encoding three antibacterial peptides in Hyalophora cecropia. J Biol Chem. 1991;266(18):11510–11517. doi:10.1016/S0021-9258(18)98986-6
   PubMed Web of Science ®Google Scholar
• Vizioli J, Richman AM, Uttenweiler-Joseph S, Blass C, Bulet P. The defensin peptide of the malaria vector mosquito Anopheles gambiae: antimicrobial activities and expression in adult mosquitoes. Insect Biochem Mol Biol. 2001;31(3):241–248. doi:10.1016/S0965-1748(00)00143-0
   PubMed Web of Science ®Google Scholar
• Bals R, Koczulla AR, Von DG. The human peptide antibiotic LL-37/hCAP-18 is an inducer of angiogenesis. J Clin Invest. 2003;111(11):1665–1672.
   PubMed Web of Science ®Google Scholar
• Braun K, Pochert A, Lindén M, et al. Membrane interactions of mesoporous silica nanoparticles as carriers of antimicrobial peptides. J Colloid Interface Sci. 2016;475:161–170. doi:10.1016/j.jcis.2016.05.002
   PubMed Web of Science ®Google Scholar
• Friedrich CL, Rozek A, Patrzykat A, Hancock REW. Structure and mechanism of action of an indolicidin peptide derivative with improved activity against gram-positive bacteria. J Biol Chem. 2001;276(26):24015–24022. doi:10.1074/jbc.M009691200
   PubMed Web of Science ®Google Scholar
• Staubitz P, Peschel A, Nieuwenhuizen WF, et al. Structure–function relationships in the tryptophan‐rich, antimicrobial peptide indolicidin. J Pept Sci. 2010;7:552.
   Google Scholar
• Himanshu K, Kaznessis YN. Structure of the antimicrobial beta-hairpin peptide protegrin-1 in a DLPC lipid bilayer investigated by molecular dynamics simulation. Biochim Biophys Acta. 2007;1768(3):509–520. doi:10.1016/j.bbamem.2006.11.015
   PubMed Web of Science ®Google Scholar
• Guerrero E, Saugar JM, Matsuzaki K, Rivas L. Role of positional hydrophobicity in the leishmanicidal activity of magainin 2. Antimicrob Agents Chemother. 2004;48(8):2980. doi:10.1128/AAC.48.8.2980-2986.2004
   PubMed Web of Science ®Google Scholar
• Tomoya T, Epand RF, Epand RM, et al. Position-dependent hydrophobicity of the antimicrobial magainin peptide affects the mode of peptide−lipid interactions and selective toxicity. Biochemistry. 2002;41(34):10723–10731. doi:10.1021/bi0256983
   PubMed Web of Science ®Google Scholar
• Mangoni ML, Papo N, Barra D, et al. Effects of the antimicrobial peptide temporin L on cell morphology,__membrane permeability and viability of Escherichia coli. Biochem J. 2004;380:859–865. doi:10.1042/bj20031975
   PubMed Web of Science ®Google Scholar
• Simmaco M, Mignogna G, Canofeni S, Miele R, Mangoni ML, Temporins BD. Antimicrobial peptides from the European red frog rana temporaria. Eur J Biochem. 1996;243(3):788–792.
   Google Scholar
• Brocal I, Falco A, Mas V, et al. Stable expression of bioactive recombinant pleurocidin in a fish cell line. Appl Microbiol Biotechnol. 2006;72(6):1217–1228. doi:10.1007/s00253-006-0393-7
   PubMed Web of Science ®Google Scholar
• Falco MO-V A, Chico V, Brocal I, Perez L, Coll JM, Estepa A. Antimicrobial peptides as model molecules for the development of novel antiviral agents in aquaculture. Mini Rev Med Chem. 2009;9(10):1.
   PubMed Web of Science ®Google Scholar
• Syvitski RT, Burton I, Mattatall NR, Douglas SE, Jakeman DL. Structural characterization of the antimicrobial peptide pleurocidin from winter flounder. Biochemistry. 2005;44(19):7282. doi:10.1021/bi0504005
   PubMed Web of Science ®Google Scholar
• Du ZQ, Jin YH. Molecular characterization and antibacterial activity analysis of two novel penaeidin isoforms from pacific white shrimp, litopenaeus vannamei. Appl Biochem Biotechnol. 2015;177(8):1607–1620. doi:10.1007/s12010-015-1840-7
   PubMed Web of Science ®Google Scholar
• Destoumieux D, Bulet P, Loew D, Van Dorsselaer A, Rodriguez J, Bachere E. Penaeidins, a new family of antimicrobial peptides isolated from the shrimp Penaeus vannamei (Decapoda). J Biol Chem. 1997;272(45):28398. doi:10.1074/jbc.272.45.28398
   PubMed Web of Science ®Google Scholar
• Charlet S, Chernysh S, Philippe H, Hetru C, Hoffmann JA, Bulet P. Innate immunity. Isolation of several cysteine-rich antimicrobial peptides from the blood of a mollusc, Mytilus edulis. J Biol Chem. 1996;271(36):21808–21813. doi:10.1074/jbc.271.36.21808
   PubMed Web of Science ®Google Scholar
• Epple P, Bohlmann AH. An Arabidopsis thaliana thionin gene is inducible via a signal transduction pathway different from that for pathogenesis-related proteins. Plant Physiol. 1995;109(3):813–820. doi:10.1104/pp.109.3.813
   PubMed Web of Science ®Google Scholar
• Vignutelli A, Wasternack C, Apel K, Bohlmann H. Systemic and local induction of an Arabidopsis thionin gene by wounding and pathogens. Plant J Cell Mol Biol. 2010;14(3):285–295. doi:10.1046/j.1365-313X.1998.00117.x
   Google Scholar
• Berrocal-Lobo M, Segura A, Moreno M, Lopez G, Garcia-Olmedo F, Molina A. Snakin-2, an antimicrobial peptide from potato whose gene is locally induced by wounding and responds to pathogen infection. Plant Physiol. 2002;128(3):951–961. doi:10.1104/pp.010685
   PubMed Web of Science ®Google Scholar
• Mao Z, Zheng J, Wang Y, et al. The new CaSn gene belonging to the snakin family induces resistance against root-knot nematode infection in pepper. Phytoparasitica. 2011;39(2):151–164. doi:10.1007/s12600-011-0149-5
   Web of Science ®Google Scholar
• Hiroo Y, Koji O, Kazuhiko T, Nobuo I. Mode of antibacterial action by gramicidin S. J Biochem. 1986;100(5):1253.
   PubMed Web of Science ®Google Scholar
• Gause GF, Brazhnikova MG. Gramicidin S and its use in the treatment of infected wounds. Nature. 1944;154(3918):703. doi:10.1038/154703a0
   Google Scholar
• Kaletta C, Entian KD. Nisin, a peptide antibiotic: cloning and sequencing of the nisA gene and posttranslational processing of its peptide product. J Bacteriol. 1989;171(3):1597–1601. doi:10.1128/jb.171.3.1597-1601.1989
   PubMed Web of Science ®Google Scholar
• Garcíagarcer MJ, Elferink MGL, Driessen AJM, Konings WN. In vitro pore-forming activity of the lantibiotic nisin. Role of protonmotive force and lipid composition. Eur J Biochem. 2010;212(2):417–422. doi:10.1111/j.1432-1033.1993.tb17677.x
   Google Scholar
• Wang Y-P, Lai R. Insect antimicrobial peptides: structures, properties and gene regulation. Zool Res. 2010;31(1):27–34. doi:10.3724/SP.J.1141.2010.01027
   Google Scholar
• Sitaram N, Nagaraj R. Host-defense antimicrobial peptides: importance of structure for activity. Curr Pharm Des. 2002;8(9):727–742. doi:10.2174/1381612023395358
   PubMed Web of Science ®Google Scholar
• Lohner K. New strategies for novel antibiotics: peptides targeting bacterial cell membranes. Gen Physiol Biophys. 2009;28(2):105. doi:10.4149/gpb_2009_02_105
   PubMed Web of Science ®Google Scholar
• Jenssen H, Hamill P, Hancock REW. Peptide antimicrobial agents. Clin Microbiol Rev. 2006;19(3):491–511. doi:10.1128/CMR.00056-05
   PubMed Web of Science ®Google Scholar
• Zhang S, Zhu L, Yu J, et al. Evaluating the potential of a loop-extended scorpion toxin-like peptide as a protein scaffold. Protein Eng Des Sel. 2016;12:12.
   Google Scholar
• Irudayam SJ, Berkowitz ML. Influence of the arrangement and secondary structure of melittin peptides on the formation and stability of toroidal pores. Biochim Biophys Acta. 2011;1808(9):2258–2266. doi:10.1016/j.bbamem.2011.04.021
   PubMed Web of Science ®Google Scholar
• Bechinger B, Zasloff M, Opella SJ. Structure and orientation of the antibiotic peptide magainin in membranes by solid-state nuclear magnetic resonance spectroscopy. Protein Sci. 1993;2(12):2077–2084. doi:10.1002/pro.5560021208
   PubMed Web of Science ®Google Scholar
• Taylor K, Barran PE, Dorin JR. Structure-activity relationships in beta-defensin peptides. Biopolymers. 2008;90(1):1–7. doi:10.1002/bip.20900
   PubMed Web of Science ®Google Scholar
• Lele DS, Talat S, Kumari S, Srivastava N, Kaur KJ. Understanding the importance of glycosylated threonine and stereospecific action of Drosocin, a Proline rich antimicrobial peptide. Eur J Med Chem. 2015;92:637–647. doi:10.1016/j.ejmech.2015.01.032
   PubMed Web of Science ®Google Scholar
• Ju YL, Yang ST, Kim HJ, Lee SK, Kim JI. Different modes of antibiotic action of homodimeric and monomeric bactenecin, a cathelicidin-derived antibacterial peptide. Bmb Rep. 2009;42(9):586. doi:10.5483/BMBRep.2009.42.9.586
   PubMed Web of Science ®Google Scholar
• Son WS, Kim JS, Kim HE, Park SH, Lee BJ. Structural studies on the antimicrobial peptide Brevinin 1E by spectroscopic methods. Spectrosc Int J. 2003;17(2–3):127–138.
   Google Scholar
• Thaker HD, Cankaya A, Scott RW, Tew GN. Role of amphiphilicity in the design of synthetic mimics of antimicrobial peptides with gram-negative activity. ACS Med Chem Lett. 2013;4(5):481. doi:10.1021/ml300307b
   PubMed Web of Science ®Google Scholar
• Liu Y, Jasensky J, Chen Z. Molecular interactions of proteins and peptides at interfaces studied by sum frequency generation vibrational spectroscopy. Langmuir. 2012;28(4):2113–2121.
   PubMed Web of Science ®Google Scholar
• Michael Z. Antimicrobial peptides of multicellular organisms: my perspective. Adv Exp Med Biol. 2019;1117:3–6. doi:10.1007/978-981-13-3588-4_1
   PubMed Web of Science ®Google Scholar
• Brogden KA, Ackermann M, McCray PB, Tack BF. Antimicrobial peptides in animals and their role in host defences. Int J Antimicrob Agents. 2003;22(5):465–478. doi:10.1016/s0924-8579(03)00180-8
   PubMed Web of Science ®Google Scholar
• Otte JM, Zdebik AE, Brand S, et al. Effects of the cathelicidin LL-37 on intestinal epithelial barrier integrity. Regul Pept. 2009;156(1–3):104–117. doi:10.1016/j.regpep.2009.03.009
   PubMedGoogle Scholar
• Yang D, Biragyn A, Hoover DM, Lubkowski J, Oppenheim JJ. Multiple roles of antimicrobial defensins, cathelicidins, and eosinophil-derived neurotoxin in host defense. Annu Rev Immunol. 2004;22(1):181–215. doi:10.1146/annurev.immunol.22.012703.104603
   PubMedGoogle Scholar
• Pan CY, Lin CN, Chiou MT, Yu CY, Chien CH. The antimicrobial peptide pardaxin exerts potent anti-tumor activity against canine perianal gland adenoma. Oncotarget. 2015;6(4):2290–2301. doi:10.18632/oncotarget.2959
   PubMedGoogle Scholar
• Roudi R, Syn NL, Roudbary M. Antimicrobial peptides as biologic and immunotherapeutic agents against cancer: a comprehensive overview. Front Immunol. 2017;8:1320.
   PubMed Web of Science ®Google Scholar
• Leite ML, da Cunha NB, Costa FF. Antimicrobial peptides, nanotechnology, and natural metabolites as novel approaches for cancer treatment. Pharmacol Ther. 2018;183:160–176.
   PubMed Web of Science ®Google Scholar
• Hancock REW, Diamond G. The role of cationic antimicrobial peptides in innate host defences. Trends Microbiol. 2000;8(9):402–410. doi:10.1016/s0966-842x(00)01823-0
   PubMed Web of Science ®Google Scholar
• Suarez-Carmona M, Hubert P, Delvenne P, Herfs MD. “Simple” antimicrobial peptides or broad-spectrum molecules? Cytokine Growth Factor Rev. 2015;26(3):361–370. doi:10.1016/j.cytogfr.2014.12.005
   PubMed Web of Science ®Google Scholar
• Batista Araujo J, Sastre de Souza G, Lorenzon EN. Indolicidin revisited: biological activity, potential applications and perspectives of an antimicrobial peptide not yet fully explored. World J Microbiol Biotechnol. 2022;38(3):39. doi:10.1007/s11274-022-03227-2
   PubMed Web of Science ®Google Scholar
• Scavello F, Amiche M, Ghia J-E. Recent advances in multifunctional antimicrobial peptides as immunomodulatory and anticancer therapy: chromogranin a-derived peptides and dermaseptins as endogenous versus exogenous actors. Pharmaceutics. 2022;14(10):2014. doi:10.3390/pharmaceutics14102014
   PubMed Web of Science ®Google Scholar
• Bhargava A, Osusky M, Hancock RE, Forward BS, Kay WW, Misra S. Antiviral indolicidin variant peptides: evaluation for broad-spectrum disease resistance in transgenic Nicotiana tabacum. Plant Sci. 2007;172(3):515–523. doi:10.1016/j.plantsci.2006.10.016
   Web of Science ®Google Scholar
• Jang WS, Edgerton M. Salivary histatins: structure, function, and mechanisms of antifungal activity. Candida Candidiasis. 2011;185–194.
   Google Scholar
• Matejuk A, Leng Q, Begum MD, et al. Peptide-based antifungal therapies against emerging infections. Drugs Future. 2010;35(3):197. doi:10.1358/dof.2010.35.3.1452077
   PubMed Web of Science ®Google Scholar
• Pistolic J, Cosseau C, Li Y, et al. Host defence peptide LL-37 induces IL-6 expression in human bronchial epithelial cells by activation of the NF-kappaB signaling pathway. J Innate Immun. 2009;1(3):254–267. doi:10.1159/000171533
   PubMed Web of Science ®Google Scholar
• Robinson WE, McDougall B, Tran D, Selsted ME. Anti-HIV-1 activity of indolicidin, an antimicrobial peptide from neutrophils. J Leukoc Biol. 1998;63(1):94–100. doi:10.1002/jlb.63.1.94
   PubMed Web of Science ®Google Scholar
• Klotman ME, Chang TL. Defensins in innate antiviral immunity. Nat Rev Immunol. 2006;6(6):447–456. doi:10.1038/nri1860
   PubMed Web of Science ®Google Scholar
• Guo C, Cong P, He Z, et al. Inhibitory activity and molecular mechanism of protegrin-1 against porcine reproductive and respiratory syndrome virus in vitro. Antivir Ther. 2015;20(6):573–582. doi:10.3851/IMP2918
   PubMed Web of Science ®Google Scholar
• Pretzel J, Mohring F, Rahlfs S, Becker K. Antiparasitic peptides. In: Yellow Biotechnology I: Insect Biotechnologie in Drug Discovery and Preclinical Research. Springer; 2013:157–192.
   Google Scholar
• Tornesello AL, Borrelli A, Buonaguro L, Buonaguro FM, Tornesello ML. Antimicrobial peptides as anticancer agents: functional properties and biological activities. Molecules. 2020;25(12):2850. doi:10.3390/molecules25122850
   PubMed Web of Science ®Google Scholar
• Hirsch T, Spielmann M, Zuhaili B, et al. Human beta-defensin-3 promotes wound healing in infected diabetic wounds. J Gene Med. 2009;11(3):220–228. doi:10.1002/jgm.1287
   PubMed Web of Science ®Google Scholar
• Tomioka H, Nakagami H, Tenma A, et al. Novel anti-microbial peptide SR-0379 accelerates wound healing via the PI3 kinase/Akt/mTOR pathway. PLoS One. 2014;9(3):e92597. doi:10.1371/journal.pone.0092597
   PubMed Web of Science ®Google Scholar
• Mader JS, Hoskin DW. Cationic antimicrobial peptides as novel cytotoxic agents for cancer treatment. Expert Opin Invest Drugs. 2006;15(8):933–946. doi:10.1517/13543784.15.8.933
   PubMed Web of Science ®Google Scholar
• Feix SJB. Peptide–membrane interactions and mechanisms of membrane destruction by amphipathic α-helical antimicrobial peptides. Biochim Biophys Acta. 2006;1758(9):1245–1256.
   PubMed Web of Science ®Google Scholar
• Hoskin DW, Ramamoorthy A. Studies on anticancer activities of antimicrobial peptides. Biochim Biophys Acta. 2008;1778(2):357–375. doi:10.1016/j.bbamem.2007.11.008
   PubMed Web of Science ®Google Scholar
• Yang P, Ramamoorthy A, Chen Z. Membrane orientation of MSI-78 measured by sum frequency generation vibrational spectroscopy. Langmuir. 2011;27(12):7760.
   PubMed Web of Science ®Google Scholar
• Papo N, Braunstein A, Eshhar Z, Shai Y. Suppression of human prostate tumor growth in mice by a cytolytic d -, l -amino acid peptide. Cancer Res. 2004;64(16):5779–5786. doi:10.1158/0008-5472.CAN-04-1438
   PubMed Web of Science ®Google Scholar
• Benincasa M, Runti G, Mardirossian M, Scocchi M. Non-membrane permeabilizing modes of action of antimicrobial peptides on bacteria. Curr Top Med Chem. 2016;16(1):76–88. doi:10.2174/1568026615666150703121009
   PubMed Web of Science ®Google Scholar
• He K, Ludtke SJ, Worcester DL, Huang HW. Neutron scattering in the plane of membranes: structure of alamethicin pores. Biophys J. 1996;70(6):2659–2666. doi:10.1016/S0006-3495(96)79835-1
   PubMed Web of Science ®Google Scholar
• Powers JPS, Hancock REW. The relationship between peptide structure and antibacterial activity. Peptides. 2003;24(11):0–1691. doi:10.1016/j.peptides.2003.08.023
   Web of Science ®Google Scholar
• Dobrzyńska I, Szachowicz-Petelska B, Sulkowski S, Figaszewski Z. Changes in electric charge and phospholipids composition in human colorectal cancer cells. Mol Cell Biochem. 2005;276(1–2):113–119. doi:10.1007/s11010-005-3557-3
   PubMed Web of Science ®Google Scholar
• Yoon WH, Park HD, Lim K, Hwang BD. Effect of O-glycosylated mucin on invasion and metastasis of HM7 human colon cancer cells. Biochem Biophys Res Commun. 1996;222(3):0–699. doi:10.1006/bbrc.1996.0806
   Web of Science ®Google Scholar
• Price JAR, Pethig R, Lai CN, Becker FF, Szent-Györgyi A. Changes in cell surface charge and transmembrane potential accompanying neoplastic transformation of rat kidney cells. Biochim Biophys Acta. 1987;898(2):129–136. doi:10.1016/0005-2736(87)90031-9
   PubMedGoogle Scholar
• Papo N, Shahar M, Eisenbach L, Shai Y. A novel lytic peptide composed of DL-amino acids selectively kills cancer cells in culture and in mice. J Biol Chem. 2003;278(23):21018–21023. doi:10.1074/jbc.M211204200
   PubMed Web of Science ®Google Scholar
• Chan SC, Hui L, Chen HM. Enhancement of the cytolytic effect of anti-bacterial cecropin by the microvilli of cancer cells. Anticancer Res. 1998;18(6A):4467–4474.
   PubMed Web of Science ®Google Scholar
• Domagala W, Koss LG. Surface configuration of human tumor cells obtained by fine needle aspiration biopsy. Scan Electron Microsc. 1980;3(3):101–108.
   Google Scholar
• Pohl A, Lage H, Müller P, Pomorski T, Herrmann A. Transport of phosphatidylserine via MDR1 (multidrug resistance 1)P-glycoprotein in a human gastric carcinoma cell line. Biochem J. 2002;365(1):259–268. doi:10.1042/bj20011880
   PubMedGoogle Scholar
• Yu Hang L, Shi Liang Y, Guo Gan X, Ha Pan S, Qiu Teng Y, An R-H. Externalization of phosphatidylserine via multidrug resistance 1 (MDR1)/P-glycoprotein in oxalate-treated renal epithelial cells: implications for calcium oxalate urolithiasis. Int Urol Nephrol. 2016;48(2):175–181. doi:10.1007/s11255-015-1155-1
   PubMed Web of Science ®Google Scholar
• Wang KR, Yan JX, Zhang BZ, Song JJ, Jia PF, Wang R. Novel mode of action of polybia-MPI, a novel antimicrobial peptide, in multi-drug resistant leukemic cells. Cancer Lett. 2009;278(1):65–72. doi:10.1016/j.canlet.2008.12.027
   PubMed Web of Science ®Google Scholar
• Oren Z, Shai Y. Mode of action of linear amphipathic alpha-helical antimicrobial peptides. Biopolymers. 1998;47(6):451–463. doi:10.1002/(SICI)1097-0282(1998)47:6<451::AID-BIP4>3.0.CO;2-F
   PubMed Web of Science ®Google Scholar
• Priyadarshini D, Ivica J, Separovic F, de Planque MRR. Characterisation of cell membrane interaction mechanisms of antimicrobial peptides by electrical bilayer recording. Biophys Chem. 2022;281:106721. doi:10.1016/j.bpc.2021.106721
   PubMed Web of Science ®Google Scholar
• Yang L, Harroun TA, Weiss TM, Ding L, Huang HW. Barrel-stave model or toroidal model_ a case study on melittin pores. Biophys J. 2001;81(3):1475–1485. doi:10.1016/S0006-3495(01)75802-X
   PubMed Web of Science ®Google Scholar
• Yeaman MR, Yount NY. Mechanisms of antimicrobial peptide action and resistance. Pharmacol Rev. 2003;55(1):27–55. doi:10.1124/pr.55.1.2
   PubMed Web of Science ®Google Scholar
• Ludtke SJ, He K, Heller WT, Harroun TA, Yang L, Huang HW. Membrane pores induced by magainin. Biochemistry. 1996;35(43):13723–13728. doi:10.1021/bi9620621
   PubMed Web of Science ®Google Scholar
• Wang YQ, Cai JY, Ma S, Zhang X. Effects of the antimicrobial peptide magaininIIon Escherichia coli observed by atomic force microscopy. J Chin Electron Microsc Soc. 2006;25(1):52–56.
   Google Scholar
• Matsuzaki K, Murase O, Fujii N, Miyajima K. An antimicrobial peptide, magainin 2, induced rapid flip-flop of phospholipids coupled with pore formation and peptide translocation †. Biochemistry. 1996;35(35):11361–11368. doi:10.1021/bi960016v
   PubMed Web of Science ®Google Scholar
• Park SC, Kim JY, Shin SO, et al. Investigation of toroidal pore and oligomerization by melittin using transmission electron microscopy. Biochem Biophys Res Commun. 2006;343(1):222–228. doi:10.1016/j.bbrc.2006.02.090
   PubMed Web of Science ®Google Scholar
• Yamaguchi S, Hong T, Waring A, Lehrer RI, Hong M. Solid-state NMR investigations of peptide-lipid interaction and orientation of a beta-sheet antimicrobial peptide, protegrin. Biochemistry. 2002;41(31):9852–9862. doi:10.1021/bi0257991
   PubMed Web of Science ®Google Scholar
• Wu M, Maier E, Benz R, Hancock REW. Mechanism of interaction of different classes of cationic antimicrobial peptides with planar bilayers and with the cytoplasmic membrane of Escherichia coli ? Biochemistry. 1999;38(22):7235–7242. doi:10.1021/bi9826299
   PubMed Web of Science ®Google Scholar
• Hari L. Antimicrobial peptides in action. Journal of the American Chemical Society. 2006;128(37):12156–12161.
   PubMed Web of Science ®Google Scholar
• Aarbiou J, Tjabringa GS, Verhoosel RM, et al. Mechanisms of cell death induced by the neutrophil antimicrobial peptides α-defensins and LL-37. Inflamm Res. 2006;55(3):119–127. doi:10.1007/s00011-005-0062-9
   PubMed Web of Science ®Google Scholar
• Liu ZY, Xu T, Zheng ST, Zhang LT, Zhang FC. Study on the interaction mechanism of antimicrobial peptide Cecropin-XJ in Xinjiang silkworm and Staphylococcus aureus DNA by spectra. Spectrosc Spectral Anal. 2008;28(3):612–616.
   Web of Science ®Google Scholar
• Wang F, Zhang SQ, Dai ZY. Studies on the action of the CM4-ABP anti K562 cancer cells by SCGE. Prog Biochem Biophys. 1998;1998:1.
   Google Scholar
• Jaynes JM. Lytic peptides, use for growth, infection and cancer. Schweiz Pat. 2000;1:38.
   Google Scholar
• Chen HM, Leung KW, Thakur NN, Tan A, Jack RW. Distinguishing between different pathways of bilayer disruption by the related antimicrobial peptides cecropin B, B1 and B3. Eur J Biochem. 2003;270(5):911–920. doi:10.1046/j.1432-1033.2003.03451.x
   PubMedGoogle Scholar
• Theansungnoen T, Maijaroen S, Jangpromma N, et al. Cationic antimicrobial peptides derived fromCrocodylus siamensisLeukocyte extract, revealing anticancer activity and apoptotic induction on human cervical cancer cells. Protein J. 2016;35(3):202–211. doi:10.1007/s10930-016-9662-1
   PubMed Web of Science ®Google Scholar
• Chavakis T, Cines DB, Rhee JS, et al. Regulation of neovascularization by human neutrophil peptides (α-defensins): a link between inflammation and angiogenesis. FASEB J. 2004;18(11):1306–1308. doi:10.1096/fj.03-1009fje
   PubMed Web of Science ®Google Scholar
• Lee HS, Chan BP, Kim JM, et al. Mechanism of anticancer activity of buforin IIb, a histone H2A-derived peptide. Cancer Lett. 2008;271(1):0–55. doi:10.1016/j.canlet.2008.05.041
   Web of Science ®Google Scholar
• Bhat S, Milner S. Antimicrobial peptides in burns and wounds. Curr Protein Peptide Sci. 2007;8(5):506–520. doi:10.2174/138920307782411428
   PubMed Web of Science ®Google Scholar
• Hiemstra PS, Amatngalim GD, Does AMVD, Taube C. Antimicrobial peptides and innate lung defenses: role in infectious and noninfectious lung diseases and therapeutic applications. Chest. 2016;149(2):545–551. doi:10.1378/chest.15-1353
   PubMed Web of Science ®Google Scholar
• Davidson DJ, Currie AJ, Reid GS, et al. The cationic antimicrobial peptide LL-37 modulates dendritic cell differentiation and dendritic cell-induced T cell polarization. J Immunol. 2004;172(2):1146–1156. doi:10.4049/jimmunol.172.2.1146
   PubMed Web of Science ®Google Scholar
• Xia L, Wu Y, Ma JI, Yang J, Zhang F. The antibacterial peptide from Bombyx mori cecropinXJ induced growth arrest and apoptosis in human hepatocellular carcinoma cells. Oncol Lett. 2016;12(1):57–62. doi:10.3892/ol.2016.4601
   PubMed Web of Science ®Google Scholar
• Deslouches B, Di YP. Antimicrobial peptides with selective antitumor mechanisms: prospect for anticancer applications. Oncotarget. 2017;8(28):46635.
   PubMedGoogle Scholar
• Balandin SV, Emelianova AA, Kalashnikova MB, Kokryakov VN, Shamova OV, Ovchinnikova TV. Molecular mechanisms of antitumor effect of natural antimicrobial peptides. Russ J Bioorganic Chem. 2016;42(6):575–589. doi:10.1134/S1068162016060029
   Web of Science ®Google Scholar
• Saravanan D, Mohammed Al-Kassim H. A Review Of Potential Anticancers From Antimicrobial Peptides. Int J Pharm Pharm Sci. 2015;7(4):19–26.
   Google Scholar
• Papo N, Shai Y. Host defense peptides as new weapons in cancer treatment. Cell Mol Life Sci Cmls. 2005;62(7–8):784–790. doi:10.1007/s00018-005-4560-2
   PubMed Web of Science ®Google Scholar
• Jacob L, Zasloff M. Potential therapeutic applications of magainins and other antimicrobial agents of animal origin. Ciba Found Symp. 1994;186:197. doi:10.1002/9780470514658.ch12
   PubMedGoogle Scholar
• Baker MA, Maloy WL, Zasloff M, Jacob LS. Anticancer efficacy of Magainin2 and analogue peptides. Cancer Res. 1993;53(13):3052.
   PubMed Web of Science ®Google Scholar
• Chen HM, Wei W, Smith D, Chan SC. Effects of the anti-bacterial peptide cecropin B and its analogs, cecropins B-1 and B-2, on liposomes, bacteria, and cancer cells. Biochim Biophys Acta. 1997;1336(2):171–179. doi:10.1016/S0304-4165(97)00024-X
   PubMed Web of Science ®Google Scholar
• Moore A, Devine D, Bibby MC. Preliminary experimental anticancer activity of cecropins. Pept Res. 1994;7(5):265–269.
   PubMedGoogle Scholar
• Selsted ME, Harwig SS, Ganz T, Schilling JW, Lehrer RI. Primary structures of three human neutrophil defensins. J Clin Invest. 1985;76(4):1436–1439. doi:10.1172/JCI112121
   PubMed Web of Science ®Google Scholar
• Pausch T, Adolph S, Felix K, et al. Antimicrobial peptide human neutrophil peptide 1 as a potential link between chronic inflammation and ductal adenocarcinoma of the pancreas. Pancreas. 2018;47(5):561–567. doi:10.1097/MPA.0000000000001054
   PubMed Web of Science ®Google Scholar
• Nishimura M, Abiko Y, Kurashige Y, et al. Effect of defensin peptides on eukaryotic cells: primary epithelial cells, fibroblasts and squamous cell carcinoma cell lines. J Dermatol Sci. 2004;36(2):87–95. doi:10.1016/j.jdermsci.2004.07.001
   PubMed Web of Science ®Google Scholar
• Strzelecka P, Czaplinska D, Sadej R, Wardowska A, Pikula M, Lesner A. Simplified, serine-rich theta-defensin analogues as antitumour peptides. Chem Biol Drug Des. 2017;90(1):52–63. doi:10.1111/cbdd.12927
   PubMed Web of Science ®Google Scholar
• Bensch KW, Raida M, M/igert H-J, Schulz-Knappe P, Forssmann W-G. hBD-I_ a novel fl-defensin from human plasma. FEBS Lett. 1995;368:331–335. doi:10.1016/0014-5793(95)00687-5
   PubMed Web of Science ®Google Scholar
• Baindara P, Gautam A, Raghava GPS, Korpole S. Anticancer properties of a defensin like class IId bacteriocin Laterosporulin10. Sci Rep. 2017;7:46541. doi:10.1038/srep46541
   PubMed Web of Science ®Google Scholar
• Gerashchenko OL, Zhuravel EV, Skachkova OV, et al. Biologic activities of recombinant human-beta-defensin-4 toward cultured human cancer cells. Exp Oncol. 2013;35(2):76.
   PubMedGoogle Scholar
• Bellamy WR, Takase M, Wakabayashi H, Kawase K, Tomita M. Antibacterial spectrum of lactoferricin B, a potent bactericidal peptide derived from the N-terminal region of bovine lactoferrin. J Appl Bacteriol. 1993;73(6):472–479. doi:10.1111/j.1365-2672.1992.tb05007.x
   Google Scholar
• Eliassen LT, Berge G, Leknessund A, Wikman M, Ø R. The antimicrobial peptide, Lactoferricin B, is cytotoxic to neuroblastoma cells in vitro and inhibits xenograft growth in vivo. Int J Cancer. 2006;119(3):493–500. doi:10.1002/ijc.21886
   PubMed Web of Science ®Google Scholar
• Yerly VC, Jorge RG, Yadi UAP, et al. Antibacterial synthetic peptides derived from bovine lactoferricin exhibit cytotoxic effect against MDA-MB-468 and MDA-MB-231 breast cancer cell lines. Molecules. 2017;22(10):1.
   Web of Science ®Google Scholar
• Suttmann H, Retz M, Paulsen F, Harder J, Lehmann J. Antimicrobial peptides of the cecropin-family show potent antitumor activity against bladder cancer cells. BMC Urol. 2008;8(1):5. doi:10.1186/1471-2490-8-5
   PubMedGoogle Scholar
• Cerón JM, Contreras-Moreno J, Puertollano E, Gád C, Puertollano MA, Pablo MAD. The antimicrobial peptide cecropin A induces caspase-independent cell death in human promyelocytic leukemia cells. Peptides. 2010;31(8):0–1503. doi:10.1016/j.peptides.2010.05.008
   Web of Science ®Google Scholar
• Liu S, Yang H, Wan L, Cai HW, Lu XF. Enhancement of cytotoxicity of antimicrobial peptide magainin II in tumor cells by bombesin-targeted delivery. Acta Pharmacol Sin. 2011;32(1):79–88. doi:10.1038/aps.2010.162
   PubMed Web of Science ®Google Scholar
• Liu S, Yang H, Wan L, Cheng J, Lu X. Penetratin-mediated delivery enhances the antitumor activity of the cationic antimicrobial peptide magainin II. Cancer Biother Radiopharm. 2013;28(4):289–297. doi:10.1089/cbr.2012.1328
   PubMed Web of Science ®Google Scholar
• Bepler G, Carney DN, Nau MM, Gazdar AF, Minna JD. Antitumor activity of magainin analogues against human lung cancer cell lines. Cancer Res. 1992;52(13):3534–3538.
   PubMed Web of Science ®Google Scholar
• Kim R, Emi M, Tanabe K. Role of mitochondria as the gardens of cell death. Cancer Chemother Pharmacol. 2006;57(5):545–553. doi:10.1007/s00280-005-0111-7
   PubMed Web of Science ®Google Scholar
• Gauldie J, Hanson JM, Shipolini RA, Vernon CA. The structures of some peptides from bee venom. FEBS J. 2008;83(2):405–410.
   Google Scholar
• Sui SF, Wu H, Guo Y, Chen KS. Conformational changes of melittin upon insertion into phospholipid monolayer and vesicle. J Biochem. 1994;116(3):482. doi:10.1093/oxfordjournals.jbchem.a124550
   PubMed Web of Science ®Google Scholar
• Risso A, Braidot E, Sordano MC, et al. BMAP-28, an antibiotic peptide of innate immunity, induces cell death through opening of the mitochondrial permeability transition pore. Mol Cell Biol. 2002;22(6):1926–1935. doi:10.1128/mcb.22.6.1926-1935.2002
   PubMed Web of Science ®Google Scholar
• Skerlavaj B, Gennaro R, Bagella L, Merluzzi L, Risso A, Zanetti M. Biological characterization of two novel cathelicidin-derived peptides and identification of structural requirements for their antimicrobial and cell lytic activities. J Biol Chem. 1996;271(45):28375–28381. doi:10.1074/jbc.271.45.28375
   PubMed Web of Science ®Google Scholar
• Ren SX, Jin S, Cheng ASL, et al. FK-16 derived from the anticancer peptide LL-37 induces caspase-independent apoptosis and autophagic cell death in colon cancer cells. PLoS One. 2013;8:1.
   Web of Science ®Google Scholar
• Zanetti M. Cathelicidins, multifunctional peptides of the innate immunity. J Leukoc Biol. 2004;75(1):39–48. doi:10.1189/jlb.0403147
   PubMed Web of Science ®Google Scholar
• Xu N, Yuan HY, Wang FL, Liao XY, Chang YP. Effect of hCAP-18/LL-37 gene transfection on proliferation and apoptosis of Lewis cells. J Jilin Univ Med Ed. 2009;35(6):1040–1043.
   Google Scholar
• Zoggel HV, Carpentier G, Santos CD, et al. Antitumor and angiostatic activities of the antimicrobial peptide dermaseptin B2. PLoS One. 2012;7(9):1.
   Web of Science ®Google Scholar
• Dong Z, Hu H, Yu X, et al. Novel frog skin-derived peptide dermaseptin-PP for lung cancer treatment: in vitro/vivo evaluation and anti-tumor mechanisms study. Front Chem. 2020;8:476. doi:10.3389/fchem.2020.00476
   PubMed Web of Science ®Google Scholar
• Che W, Li-Li T, Song L, et al. Rapid cytotoxicity of antimicrobial peptide tempoprin-1CEa in breast cancer cells through membrane destruction and intracellular calcium mechanism. PLoS One. 2013;8(4):e60462. doi:10.1371/journal.pone.0060062
   PubMed Web of Science ®Google Scholar
• Wang C, Zhou Y, Li S, et al. Anticancer mechanisms of temporin-1CEa, an amphipathic α-helical antimicrobial peptide, in Bcap-37 human breast cancer cells. Life Sci. 2013;92(20–21):1004–1014. doi:10.1016/j.lfs.2013.03.016
   PubMed Web of Science ®Google Scholar
• Wang C, Chen YW, Zhang L, et al. Melanoma cell surface-expressed phosphatidylserine as a therapeutic target for cationic anticancer peptide, temporin-1CEa. J Drug Target. 2016;24(6):548–556.
   PubMed Web of Science ®Google Scholar
• Ouyang GL, Li QF, Peng XX, Liu QR, Hong SG. Effects of tachyplesin on proliferation and differentiation of human hepatocellular carcinoma SMMC-7721 cells. World J Gastroenterol. 2002;8(6):1053–1058. doi:10.3748/wjg.v8.i6.1053
   PubMed Web of Science ®Google Scholar
• Chen Y, Xu X, Hong S, Chen J, Zhang L. RGD-tachyplesin inhibits tumor growth. Cancer Res. 2001;61(6):2434–2438.
   PubMed Web of Science ®Google Scholar
• Hilchie AL, Doucette CD, Pinto DM, Patrzykat A, Douglas S, Hoskin DW. Pleurocidin-family cationic antimicrobial peptides are cytolytic for breast carcinoma cells and prevent growth of tumor xenografts. Breast Cancer Res. 2011;13(5):1–16. doi:10.1186/bcr3043
   Web of Science ®Google Scholar
• Kim S, Kim SS, Bang YJ, Kim SJ, Lee BJ. In vitro activities of native and designed peptide antibiotics against drug sensitive and resistant tumor cell lines. Peptides. 2003;24(7):945–953. doi:10.1016/S0196-9781(03)00194-3
   PubMed Web of Science ®Google Scholar
• Jing H. Effects of Antimicrobial Peptides Temporin-1CEa on Multidrug Resistance of MCF-7/Adr Cells. Liaoning Normal University; 2016. Chinese.
   Google Scholar
• To KKW, Ren SX, Wong CCM, Cho CH. Reversal of ABCG2-mediated multidrug resistance by human cathelicidin and its analogs in cancer cells. Peptides. 2013;40:13–21. doi:10.1016/j.peptides.2012.12.019
   PubMed Web of Science ®Google Scholar
• Shan GUO, Rui-jun ZHAO, Jing-xia C. Effect of antimicrobial peptides on proliferation and multidrug resistance in multidrug resistant human hepatocellular carcinoma Bel-7402/ADM cells. Journal Article. Chin J Public Health. 2019;35(01):48–52. Chinese.
   Google Scholar
• Hui L, Leung K, Chen HM. The combined effects of antibacterial peptide cecropin A and anti-cancer agents on leukemia cells. Anticancer Res. 2002;22(5):2811–2816.
   PubMed Web of Science ®Google Scholar
• Do N, Weindl G, Grohmann L, et al. Cationic membrane-active peptides - anticancer and antifungal activity as well as penetration into human skin. Exp Dermatol. 2014;23(5):326–331. doi:10.1111/exd.12384
   PubMed Web of Science ®Google Scholar
• Xia L, Zhang F. Effect of Cecropin-XJ and it’ s combination with chemotherapeutic agents on the proliferation and apoptosis of human esophageal cancer Eca109 cells. Chin J Cancer Biother. 2014;21(4):402–407.
   Google Scholar
• Francesca M, Marina G, Elena R. Conjugation of photosensitisers to antimicrobial peptides increases the efficiency of photodynamic therapy in cancer cells. Photochem Photobiol Sci. 2015;2015:1.
   Google Scholar
• Wang X, Donghui LI. Effect of APBMV on large intestine cancer LoVo cells and its synergetic effect with chemotherapy drugs. Qianw J Med. 2003;2003:1.
   Google Scholar
• Wang X, Donghui LI, Gao C. Antitumor effect of ant icancer polypeptide from buthus martensii venom: experiment in vivo. Qianw J Med. 2003;2003:1.
   Google Scholar
• Zhang B, Shi W, Li J, et al. Synthesis and biological evaluation of novel peptides based on antimicrobial peptides as potential agents with antitumor and multidrug resistance‐reversing activities. Chem Biol Drug Des. 2017;2017:1.
   Google Scholar
• Johnstone S, Gelmon K, Mayer LD, Hancock RE, Bally MB. In vitro characterization of the anticancer activity of membrane-active cationic peptides. I. Peptide-mediated cytotoxicity and peptide-enhanced cytotoxic activity of doxorubicin against wild-type and P-glycoprotein over-expressing tumor cell lines. Anticancer Drug Des. 2000;15(2):151–160.
   PubMedGoogle Scholar
• Winder D, Günzburg WH, Erfle V, Salmons B. Expression of antimicrobial peptides has an antitumour effect in human cells. Biochem Biophys Res Commun. 1998;242(3):0–612. doi:10.1006/bbrc.1997.8014
   Web of Science ®Google Scholar
• Ling C-Q, Li B, Zhang C. Inhibitory effect of recombinant adenovirus carrying melittin gene on hepatocellular carcinoma. Ann Oncol. 2005;16(1):109–115. doi:10.1093/annonc/mdi019
   PubMed Web of Science ®Google Scholar
• Xu B, Dong CY, Zhang F, Lin YM, Wu KF, Ma XT. Synergistic antileukemia effect of combinational gene therapy using murine b-defensin 2 and IL-18 in L1210 murine leukemia model. Gene Ther. 2007;14(15):1181–1187. doi:10.1038/sj.gt.3302966
   PubMed Web of Science ®Google Scholar
• Zou M, Zhang L, Xie Y, Xu W. NGR-based strategies for targeting delivery of chemotherapeutics to tumor vasculature. Anticancer Agents Med Chem. 2012;12(3):1.
   Web of Science ®Google Scholar
• Chakravarty R, Chakraborty S, Dash A. Molecular imaging of breast cancer: role of RGD peptides. Mini Rev Med Chem. 2015;15(13):1073–1094. doi:10.2174/1389557515666150909144606
   PubMed Web of Science ®Google Scholar
• Me M, Myrberg H, El-Andaloussi S, l L. Design of a tumor homing cell-penetrating peptide for drug delivery. Int J Pept Res Ther. 2009;15(1):11–15. doi:10.1007/s10989-008-9156-x
   Web of Science ®Google Scholar
• Ma XY, Shu L, Luo DF, Liu RH, Ling X. Antitumor and antimetastatic effect of antimicrobial peptide conjugated with tumor homing peptide TMTP1 on the transplanted prostate cancer and gastric cancer in nude mice. Zhonghua Zhong Liu Za Zhi. 2013;35(10):737–741.
   PubMedGoogle Scholar
• Liu S, Yang H, Cai H, Wan L, Lu X. Enhancement of cytotoxicity of cantionic antimicrobial peptide in tumor cells by conjugation to cell-penetrating peptide. J Biomed Eng. 2011;28(1):110.
   Google Scholar
• Jing H, Cuixia C, Shengzhong Z, et al. Designed antimicrobial and antitumor peptides with high selectivity. Biomacromolecules. 2011;12(11):3839–3843. doi:10.1021/bm201098j
   PubMed Web of Science ®Google Scholar
• Urban P, Jose Valle-Delgado J, Moles E, Marques J, Diez C, Fernandez-Busquets X. Nanotools for the delivery of antimicrobial peptides. Curr Drug Targets. 2012;13(9):1158–1172. doi:10.2174/138945012802002302
   PubMed Web of Science ®Google Scholar
• Strand A. Values in nanomedical research: a discussion based on the NANOCAN project on nanoparticles in cancer therapy and diagnosis. Nanoethics. 2017;11(3):259–271. doi:10.1007/s11569-017-0295-4
   Web of Science ®Google Scholar
• Becker C, Bopp T, Jonuleit H. Treg cells as potential cellular targets for functionalized nanoparticles in cancer therapy. Nanomedicine. 2016;11(20):2699–2709. doi:10.2217/nnm-2016-0197
   PubMed Web of Science ®Google Scholar
• Swenson S, Costa F, Minea R, et al. Intravenous liposomal delivery of the snake venom disintegrin contortrostatin limits breast cancer progression. Mol Cancer Ther. 2004;3(4):499–511. doi:10.1158/1535-7163.499.3.4
   PubMed Web of Science ®Google Scholar
• Tian W, Li B, Zhang X, Dang W, Chen T. Suppression of tumor invasion and migration in breast cancer cells following delivery of siRNA against Stat3 with the antimicrobial peptide PR39. Oncol Rep. 2012;28(4):1362–1368. doi:10.3892/or.2012.1911
   PubMed Web of Science ®Google Scholar
• Ines N. Antimicrobial and cell-penetrating peptides: how to understand two distinct functions despite similar physicochemical properties. Adv Exp Med Biol. 2019;1117:93–109. doi:10.1007/978-981-13-3588-4_7
   PubMed Web of Science ®Google Scholar
• Splith K, Neundorf I. Antimicrobial peptides with cell-penetrating peptide properties and vice versa. Eur Biophys J. 2011;40(4):387–397. doi:10.1007/s00249-011-0682-7
   PubMed Web of Science ®Google Scholar
• Liu CY, Xiao YZ, Li RS, Li XR, Yuan HL. Preparation and in vitro evaluation of antibacterial peptides from Plutella xylostella poly(lactic-co-glycolic acid) nanoparticles. Chin Traditional Herbal Drugs. 2015;46(3):348–352.
   Google Scholar
• Soman NR, Baldwin SL, Hu G, et al. Molecularly targeted nanocarriers deliver the cytolytic peptide melittin specifically to tumor cells in mice, reducing tumor growth. J Clin Invest. 2009;119(9):2830–2842. doi:10.1172/JCI38842
   PubMed Web of Science ®Google Scholar
• Badr G, Al-Sadoon MK, El-Toni AM, Daghestani M. Walterinnesia aegyptia venom combined with silica nanoparticles enhances the functioning of normal lymphocytes through PI3K/AKT, NFκB and ERK signaling. Lipids Health Dis. 2012;11:1.
   PubMed Web of Science ®Google Scholar
• Badr G, Al-Sadoon MK, Rabah DM, Sayed D. Snake (Walterinnesia aegyptia) venom-loaded silica nanoparticles induce apoptosis and growth arrest in human prostate cancer cells. Apoptosis. 2012;18(3):1.
   Web of Science ®Google Scholar
• Al-Sadoon MK, Rabah DM, Badr G. Enhanced anticancer efficacy of snake venom combined with silica nanoparticles in a murine model of human multiple myeloma: molecular targets for cell cycle arrest and apoptosis induction. Cell Immunol. 2013;284(1–2):129–138. doi:10.1016/j.cellimm.2013.07.016
   PubMed Web of Science ®Google Scholar
• Tan H, Huang Y, Xu J, et al. Spider toxin peptide lycosin-I functionalized gold nanoparticles for in vivo tumor targeting and therapy. Toxicon. 2019:158. doi:10.1016/j.toxicon.2019.07.005
   PubMed Web of Science ®Google Scholar
• Di WU, Zhao Y, Ren HD, Xin-Hong SI, Zhang L, Wang C. Construction of cationic anticancer peptide temporin-1CEa liposomes and evaluation of anti-breast cancer activity in vitro. Chin J Biochem Pharmaceutics. 2016;6 :22–26.
   Google Scholar
• Wang C, Dong S, Zhang L, et al. Cell surface binding, uptaking and anticancer activity of L-K6, a lysine/leucine-rich peptide, on human breast cancer MCF-7 cells. Entific Rep. 2017;7(1):8293.
   Google Scholar
• Chen Y-W. Preparation, Characterization and Anti-Cancer Activity Evaluation of L-K6 Antimicrobial Peptide-Liposomal Drug System. Liaoning Normal University; 2016. Chinese.
   Google Scholar
• Huang C, Jin H, Qian Y, et al. Hybrid melittin cytolytic peptide-driven ultrasmall lipid nanoparticles block melanoma growth in vivo. ACS Nano. 2013;7(7):5791–5800. doi:10.1021/nn400683s
   PubMed Web of Science ®Google Scholar
• Yamada Y, Shinohara Y, Kakudo T, et al. Mitochondrial delivery of mastoparan with transferrin liposomes equipped with a pH-sensitive fusogenic peptide for selective cancer therapy. Int J Pharm. 2005;303(1–2):1–7. doi:10.1016/j.ijpharm.2005.06.009
   PubMedGoogle Scholar
• Tseng Y-L, Liu -J-J, Hong R-L. Translocation of liposomes into cancer cells by cell-penetrating peptides penetratin and tat: a kinetic and efficacy study. Mol Pharmacol. 2002;62(4):864. doi:10.1124/mol.62.4.864
   PubMed Web of Science ®Google Scholar
• Sharma G, Modgil A, Zhong T, Sun C, Singh J. Influence of short-chain cell-penetrating peptides on transport of doxorubicin encapsulating receptor-targeted liposomes across brain endothelial barrier. Pharm Res. 2014;31(5):1194–1209. doi:10.1007/s11095-013-1242-x
   PubMed Web of Science ®Google Scholar
• Henriques S, Melo M, Castanho M. Cell-penetrating peptides and antimicrobial peptides: how different are they? Biochem J. 2006;399(1):1–7. doi:10.1042/BJ20061100
   PubMedGoogle Scholar
• Hu C, Chen X, Zhao W, Chen Y, Huang Y. Design and modification of anticancer peptides. Drug Des. 2016;5(3):1–10. doi:10.4172/2169-0138.1000138
   Google Scholar
• Giangaspero A, Sandri L, Tossi A. Amphipathic, α‐helical antimicrobial peptides. Pept Sci. 2015;55(21):4–30.
   Google Scholar
• Diao Y, Han W, Zhao H, et al. Designed synthetic analogs of the alpha-helical peptide temporin-La with improved antitumor efficacies via charge modification and incorporation of the integrin alphavbeta3 homing domain. J Pept Sci. 2012;18(7):476–486. doi:10.1002/psc.2420
   PubMed Web of Science ®Google Scholar
• Dathe M, Nikolenko H, Meyer J, Beyermann M, Bienert M. Optimization of the antimicrobial activity of magainin peptides by modification of charge. FEBS Lett. 2001;501(2–3):146–150. doi:10.1016/S0014-5793(01)02648-5
   PubMed Web of Science ®Google Scholar
• Chen Y, Guarnieri MT, Vasil AI, Vasil ML, Mant CT, Hodges RS. Role of peptide hydrophobicity in the mechanism of action of α-helical antimicrobial peptides. Antimicrob Agents Chemother. 2007;51(4):1398–1406.
   PubMed Web of Science ®Google Scholar
• Huang Y, Huang J, Chen Y. Alpha-helical cationic antimicrobial peptides: relationships of structure and function. Protein and Cell. 2010;1(2):143–152. doi:10.1007/s13238-010-0004-3
   PubMed Web of Science ®Google Scholar
• Ganz T. The role of antimicrobial peptides in innate immunity. Integr Comp Biol. 2003;43(2):300–304. doi:10.1093/icb/43.2.300
   PubMed Web of Science ®Google Scholar
• Ma XT, Xu B, An LL, Dong CY, Wu KF. Vaccine with beta-defensin 2-transduced leukemic cells activates innate and adaptive immunity to elicit potent antileukemia responses. Cancer Res. 2006;66(2):1169. doi:10.1158/0008-5472.CAN-05-2891
   PubMed Web of Science ®Google Scholar
• Zhang X, Jin L, Wang Z, Wang Q. Fusion expression of antimicrobial peptides in Escherichia coli. Chin J Biotechnol. 2014;30(8):1172.
   Google Scholar
• Fanhong K, Weixia Z, Yong C, Hongfa W. Advanced on Pichia pastoris expression of antimicrobial peptides. J Pathogen Biol. 2009;4(9):700–702.
   Google Scholar